|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
| ||||||||||||||||||||
Files in this Data Supplement:
Fig. S1. RGMc is a disulfide-linked protein. (A) Detection of adenoviral-derived HA-RGMc by immunoblotting (arrows) after crosslinking of cell-surface proteins by EZ-link and capture by ‘pull-down’ with streptavidin agarose (EZ), or after release from the cell surface by incubation with PI-PLC. Results are shown after reducing (left panel) and non-reducing (right panel) SDS-PAGE. (B) Immunoblotting with whole-cell protein extracts (WCE) and conditioned culture media (CM) from Cos-7 cells infected with Ad-HA-RGMc (wt) or Ad-HA-RGMcΔGPI (Δ) and separated under reducing (left panel) or non-reducing (right panel) SDS-PAGE.
Fig. S2. Detection of cell-associated and secreted RGMc using different reducing and denaturing conditions. Results are shown of immunoblotting with whole cell protein extracts (WCE) and conditioned culture media (CM) from Cos-7 cells infected with Ad-HA-RGMc. Before SDS-PAGE protein samples were incubated with different combinations of reducing agents (100 mM DTT, 1% β-mercaptoethanol), denaturant (8 M urea), and cysteine alkylating reagent iodoacetamide (IAN, 10 mM). Note that all treatments led to identical results.
Fig. S3. Secreted RGMc is stable following incubation at low pH. Conditioned media (10 μl) from undifferentiated C2 myoblasts infected with Ad-HA-RGMc was incubated for 2 hours at 37°C in 100 mM phosphate buffer (pH 5.0 to 8.0) or 100 mM glycine pH 2.5, followed by immunoblotting with an antibody to RGMc.
| ||||||||||||||||||||